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Abstract
Background: In Drosophila, the transport regulator Klar displays tissue-specific localization: In photoreceptors, it is
abundant on the nuclear envelope; in early embryos, it is absent from nuclei, but instead present on lipid droplets.
Differential targeting of Klar appears to be due to isoform variation. Droplet targeting, in particular, has been
suggested to occur via a variant C-terminal region, the LD domain. Although the LD domain is necessary and
sufficient for droplet targeting in cultured cells, lack of specific reagents had made it previously impossible to
analyze its role in vivo.
Results: Here we describe a new mutant allele of klar with a lesion specifically in the LD domain; this lesion
abolishes both droplet localization of Klar and the ability of Klar to regulate droplet motion. It does not disrupt
Klar’s function for nuclear migration in photoreceptors. Using a GFP-LD fusion, we show that the LD domain is not
only necessary but also sufficient for droplet targeting in vivo; it mediates droplet targeting in embryos, in ovaries,
and in a number of somatic tissues.
Conclusions: Our analysis demonstrates that droplet targeting of Klar occurs via a cis-acting sequence and
generates a new tool for monitoring lipid droplets in living tissues of Drosophila.
Background
Lipid droplets are the intracellular sites for storage of
neutral lipids. Long dismissed as inert inclusions, they
are now recognized as dynamic organelles with a myriad
of functions well beyond fat storage [reviewed in, [1],
[2]]. In many cells, lipid droplets are highly motile,
actively moving along cytoskeletal tracks [3]. Such
motion is implicated in the delivery of nutrients [4,5],
the growth and turnover of lipid droplets [6-8], the
exchange of lipids and proteins between various cellular
compartments [9-12], and even the assembly of viral
particles [13].
Despite the ubiquity and potential biological signifi-
cance of droplet motion, its mechanism is not well
understood [3]. Most characterized droplet motion
occurs along microtubules, driven by motor proteins,
such as the minus-end directed cytoplasmic dynein
[8,13-16] and the plus-end directed kinesin-1 [17]. The
same motor proteins are also employed in many other
transport processes and are responsible for the motion
of various vesicles, mitochondria, RNP particles, chro-
mosomes and nuclei. Motion of these cargoes is regu-
lated distinctly from that of lipid droplets [e.g., [18,19]].
At least in part, specificity of droplet motion is
achieved via distinct motor regulators that are present
exclusively on lipid droplets. For example, in both mam-
mals and flies, members of the Perilipin family modulate
droplet motion [6,13,20]; these proteins localize largely
or exclusively to lipid droplets [21]. In Drosophila
embryos, droplet motion is controlled by Klarsicht
(Klar) [19], a protein highly enriched on lipid droplets at
this stage of development [22]. Presumably, unique
motor regulators present only on droplets control speci-
fically those motors attached to this cargo.
Klar’s role is not limited to lipid droplets; in different
cells, Klar controls distinct transport processes. In early
embryos, it regulates the bidirectional motion of lipid
droplets [19], which are transported by cytoplasmic
dynein [14] and kinesin-1 [17]. In embryonic salivary
glands, in contrast, Klar is required for efficient trans-
port of secretory vesicles [23], possibly by modulating
the activity of cytoplasmic dynein. In developing photo-
receptors, Klar promotes apical migration of nuclei [24].
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dynein [25], and also involves the activity of kinesin-1
[26]. The intracellular localization of Klar reflects these
varying functions in different tissues: in early embryos,
Klar is present on lipid droplets [22]; in photoreceptors,
it is enriched on the nuclear envelope [24,27]. Appar-
ently, Klar regulates the same or a similar set of motors
in all these instances, and it is the location of Klar that
determines which subset of cellular motors is controlled.
Thus, determining how Klar is targeted intracellularly is
a key to understanding its cargo specificity.
This tissue-specific targeting of Klar correlates with
isoform variation [22]. The klar locus encodes at least
three protein isoforms that are due to the use of multiple
promoters and Poly A sites [22]. The alpha (a) isoform is
required for nuclear migration in photoreceptors [22,24];
the beta (b) isoform controls the motion of embryonic
lipid droplets [22]; no function has yet been described for
the gamma (g) isoform. Because the a and b isoforms are
predicted to have identical N-terminal regions of 1726
amino acids, but carry unique C-terminal regions (536 aa
for Klar a, 114 aa for Klar b), these C-terminal domains
may be cis-acting targeting sequences that dictate where
in the cell Klar accumulates [22].
For Klar a, there is ample support for this model. Its
C-terminal region contains a 60 aa KASH (Klarsicht/
ANC-1/Syne Homology) domain. KASH domains typi-
cally localize to the outer nuclear envelope, and together
with SUN domain proteins in the inner nuclear envel-
ope establish a bridge linking cytoplasmic and nucleo-
plasmic proteins [28,29]. Indeed, the KASH domain of
Klar is sufficient to target unrelated proteins to the
nuclear envelope, in cultured cells [22] as well as in
photoreceptors [30]. In addition, mutations of Klar a
that truncate the protein within or just N-terminal to
the KASH domain fail to localize to the nuclear envel-
ope [22,30]. Thus, the KASH domain is necessary and
sufficient to target Klar to the nuclear envelope.
Available evidence is consistent with the notion that
the unique C-terminal region of Klar b has an analogous
role in targeting to lipid droplets. For example, in cul-
tured cells, this so-called LD domain is sufficient to
recruit RFP to lipid droplets [22]. However, whether the
LD domain is necessary and sufficient for droplet target-
ing in vivo has not been clearly established. For one, the
exact distribution of LD fusion proteins in cultured cells
is distinct from the distribution of endogenous Klar
in vivo:i ne m b r y o s ,K l a rb is present in one or a few
dots per lipid droplet, suggesting that it may be
recruited to privileged sites [22]. In cultured cells, in
c o n t r a s t ,R F P - L Df u s i o n sa r ee venly distributed all over
the droplet surface, raising the possibility that targeting
in the two systems occurs by distinct mechanisms. From
mutational analysis, it is clear that in vivo droplet
localization requires C-terminal regions of Klar b [22].
However, all available klar alleles either only disrupt
Klar a or truncate both Klar a and Klar b within the
shared N-terminal region. Therefore, they cannot be
used to distinguish if droplet targeting is due to the Klar
b-specific LD domain or due to regions shared between
Klar a and Klar b.
To examine the role of specifically the LD domain, we
identified a new klar allele that deletes the last 64 aa of
this domain. This allele abolishes droplet localization
entirely. We also expressed a GFP-LD fusion protein
a n df i n dt h a ti tt a r g e t st ol i p i dd r o p l e t si ne a r l y
embryos, in the female germ line, and in somatic tissues.
This analysis establishes that in vivo the LD domain is
necessary and sufficient for targeting to lipid droplets.
Results
Identifying a klar allele with a lesion in the LD domain
The transcripts for Klar a and b diverge after exon 15,
followed either by exons 16, 17 and 18 (Klar a)o re x o n
15ext (Klar b) [22]. Exon 15ext encodes the LD domain.
Klar b proteins lacking C-terminal regions fail to loca-
lize to embryonic lipid droplets [22]. All characterized
klar alleles with lesions in Klar b remove not only the
LD domain (114 amino acids), but also at least 128
amino acids encoded by exons 14 and 15, exons shared
with Klar a. Thus, these reagents do not allow a conclu-
sive test if targeting to embryonic lipid droplets requires
the LD domain (unique to Klar b)o ri sm e d i a t e db y
regions common to both Klar a and Klar b.
To address this issue, we searched for new klar alleles
with lesions specifically in the LD domain. Since Klar b
null alleles are viable [22], we took advantage of a col-
lection of EMS mutagenized, homozygously viable third
chromosomes [31]. We employed TILLING (Targeting
Induced Local Lesions IN Genomes) [32-34] to find
sequence changes in a genomic region that includes klar
exon 15ext. We recovered two candidate lines (Z3-3772,
Z3-1711) with predicted sequence changes in exon
15ext. We focused on the potential klar mutation in line
Z3-3772 since it was predicted to result in deletion of
roughly half of the LD domain.
Many lines from the mutant collection are mixtures of
homozygotes and heterozygotes; the latter carry not
only the mutagenized chromosome but also a balancer
chromosome. In particular, for strain Z3-3772, the TIL-
LING analysis had employed DNA from heterozygotes
as in the extant stock homozygotes are rare to non-exis-
tent. When we extracted the non-balancer chromosome
from this stock and sequenced exon 15ext, the predicted
protein sequence of the corresponding LD domain was
identical to the canonical sequence of Klar (Figure 1A).
To reconcile this observation with the TILLING
results, we hypothesized that the mutation in the
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exon 15 exon 15ext
exon 15ext
A
B
                                                                       
canonical GEFPPPPTPRKPSSSSPVSACLRRRRRRRLGTELPGPTESGDSRQMVHMVECQCAPITRFVARVIEFVLDVGNMLEHFALYRFLAGTLRSLYELVDRPVGGRLGRFFDGLRGLF
Z3-3772 GEFPPPPTPRKPSSSSPVSACLRRRRRRRLGTELPGPTESGDSRQMVHMVECQCAPITRFVARVIEFVLDVGNMLEHFALYRFLAGTLRSLYELVDRPVGGRLGRFFDGLRGLF
Z3-1140 GEFPPPPTPRKPSSSSPVSACLRRRRRRRLGTELPGPTESGDSRQMVHMVECQCAPITRFVARVIEFVLDVGNMLEHFALYRFLAGTLRSLYELVDRPVGGRLGRFFDGLRGLF
MW GEFPPPPTPRKPSSSSPVSACLRRRRRRRLGTELPGPTESGDSRQMVHMVASWHG
Z GEFPPPPTPRKPSSSSPVSACLRRRRRRRLGTELPGPTESGDSRQMVHMVECQCAPITRFVARVIEFVLDVGNMLEHFALYRFLAGTLRSLYELVDRPVGGRLGRFFVGLRGLF
Z3-1711 GEFPPPPTPRKPSSSSPVSSCLRRRRRQRPGTELPGPTESGDSRQMVHVVECQCAPITRFVARVIEFVLDVGNMLEHFALYRFLAGTLRSLYELVDRPVGGRLGRFFVGLRGLF
Tai255.1 GEFPPPPTPRKPSSSSPVSACLRRRRRRRPGTELPGPTESGDSRQMVHVVECQCAPITRFVARVIEFVLDVGNMLEHFALYRFLAGTLRSLYELVDRPVGGRLGRFFVGLRGLF
exon 15ext
C
Figure 1 Sequence of the LD domain in various strains and species. (A) Comparison of D. melanogaster strains. Exon 15ext was sequenced
in various strains, and the encoded protein was compared to the canonical sequence available on FlyBase. Shown are the klar
MW and klar
Z
allele, the wild-type strain Tai255.1, as well as three mutagenized chromosomes from the Zuker collection (Z3-3772, Z3-1140, Z3-1711). Changes
from the canonical sequence are indicated in red. The wild-type LD domain encompasses 114 amino acids. (B) Sequence variation in the LD
domain across fly species. Candidate klar exons 15 and 15ext were identified in sixteen fly species based on sequence similarity to the
corresponding D. melanogaster exons. Predicted protein sequences were aligned with Clustal2. * = position at which residues are absolutely
conserved; : = position at which residues show similar chemical properties; . = partial conservation. Color scheme highlights chemically similar
amino acids. A 26 aa stretch in exon 15 and a 46 aa stretch in exon 15ext are highly conserved. The red arrow indicates at which point the
protein sequence of the klar
MW allele diverges from the wild-type sequence; this allele deletes the entire 46 aa conserved region (amino acids
51-96) in exon 15ext. (C) Helical wheel diagram for amino acids 57-74 of the D. melanogaster LD domain. Potentially charged residues are
represented in light blue; for uncharged residues, hydrophobicity is indicated by a scale from red (most hydrophilic) to green (most
hydrophobic). This amino-acid sequence is compatible with an amphipathic helix structure. A similar pattern of hydrophobicity is conserved
across all seventeen species shown in (B).
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Page 3 of 15parental line might exist on the balancer chromosome,
TM6B. We generated flies heterozygous for the TM6B
chromosome from line Z3-3772 and for Df(3L)emc
E12,a
large deletion that removes - among many other genes -
the entire klar locus. Genomic sequencing revealed the
absence of a contiguous 25 bp stretch in the middle of
exon 15ext.
This deletion is not a general feature of the TM6B bal-
ancer chromosome. Although many of the lines from the
mutant collection were analyzed as heterozygotes, the
deletion was recovered only once. In particular, our
screen identified sequence variations for 19 other lines
for which DNA from heterozygous flies had been charac-
terized; but for none of these lines was the 25 bp deletion
identified. We also extracted a TM6B chromosome from
a different stock of the collection and found that the
25 bp deletion was not present. Thus, this deletion in
exon 15ext did not pre-exist on the TM6B chromosome
and apparently arose spontaneously since the mutagen-
esis scheme employed to generate the collection [31] did
not expose the balancer chromosomes to EMS. In the
following, we will refer to the TM6B chromosome carry-
ing this deletion as TM6B
MW and to the corresponding
klar allele as klar
MW. The TM6B chromosome without
this deletion and the corresponding klar allele will be
called TM6B
Z and klar
Z, respectively.
What is the consequence of this change in the geno-
mic sequence? The 25 bp deletion in exon 15ext shifts
the open reading frame and should result in a truncated
LD domain: While the initial 50 amino acids are
unchanged, the C-terminal 64 residues are replaced by
an unrelated five-amino-acid sequence (Figure 1A).
To determine if klar
MW carried additional lesions, we
sequenced all the coding exons of klar in this allele. The
predicted Klar protein(s) display a number of differences
to the canonical Klar sequence available on FlyBase
(Table 1), but with the exception of the truncation of
the LD domain, all changes are also found for allele
klar
Z. Furthermore, all these additional changes have
been observed - individually or in combination - in pre-
sumably wild-type versions of Klar (Table 1) and thus
apparently represent naturally occurring, benign
variations.
The LD domain is necessary for droplet localization in
vivo
The identification of klar
MW provides an opportunity to
test the functional consequences of disrupting the LD
domain specifically. Although the other amino acid
changes encoded by klar
MW are likely benign, they
could in principle be responsible for any phenotypes
observed with klar
MW.I nt h ef o l l o w i n g ,w et h e r e f o r e
compare klar
MW to the klar
Z allele, which shares these
changes, apart from the LD domain lesion.
W ef i r s ta s k e di ft h em u t a n tK l a r
MW protein was
expressed. We extracted proteins from early embryos of
various genotypes and detected Klar by Western analysis
(Figure 2A). The Klar b null allele klar
YG3 [22] served as
specificity control. Embryos from mothers carrying
TM6B
Z over Df(3L)emc
E12 o n l yh a v eas i n g l ec o p yo ft h e
klar locus, and they express Klar b at reduced levels com-
pared to the wild type. Klar
1 protein lacks the C-terminal
286 amino acids, and therefore migrates slightly faster
than the wild-type protein [22]. Finally, Klar
MW was
expressed at similar levels to the single copy of wild-type
Klar
Z. Its apparent molecular weight was similar to that
of Klar
Z, but larger than that of Klar
1; these observations
are consistent with a lack of ~60 amino acids in Klar
MW.
To test if the mutant Klar was present on lipid dro-
plets, we employed the assay previously used [22] to
demonstrate that Klar is associated with embryonic lipid
droplets: in-vivo centrifugation [11,35]. When syncytial
embryos are centrifuged, the major organelles sort out
by density. In particular, lipid droplets accumulate on
the side of the embryo that points up during centrifuga-
tion. In the wild type, this lipid-droplet layer is highly
enriched for Klar; mutant Klar proteins that fail to tar-
get to lipid droplets are absent from this layer [22]. We
therefore determined Klar distribution in centrifuged
embryos of various genotypes (Figure 2B). While in
klar
Z Klar was highly enriched on the droplet layer, Klar
signal was absent from the droplet layer in the LD trun-
cation mutant klar
MW.W ec o n c l u d et h a tt r u n c a t i o no f
the LD domain abolishes targeting of Klar to lipid dro-
plets. Thus, the LD domain is indeed necessary for dro-
plet localization in vivo.
Table 1 Predicted sequence variation in Klar
MW
AA # Observed change Exon affected Notes
633 Ser to Thr 7 a, b
1013 Ser to Thr 9 a, b
1210 Ser to Ala 11 a, c
1358 Asp to Glu 11 a, b, c
1366 Ser to His 11 a, b, c
1510 Thr to Ser 13 a, b, c
1577 Ile to Asn 14 a, b, c
Frame shift See Fig. 1A 15ext
1887 Thr to Ser 17 a, b
1909 Ser to Ala 17 a, b
The protein coding exons of klar
MW were sequenced, and the predicted
protein sequence was compared to the wild-type Klar sequence available on
FlyBase. The position of the sequence change is given relative to the protein
sequence of the originally reported Klar a protein [24]. Exons numbering
follows the convention established previously [22]. Notes indicate if a
particular amino acid change is shared with other klar alleles.
apresent in Klar
Z.
bpresent in a wild-type Klar a cDNA (GenBank AAD43129, as reported in [24]).
cpresent in various wild-type klar alleles (S. Jangi, Y. Guo, MAW, unpublished
observations).
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in embryos
During early embryogenesis, lipid droplets display
stereotyped shifts in their overall distribution as the
relative balance of plus- and minus-end motion changes
in a temporally controlled manner [19]. In wild-type
embryos, droplets are initially found throughout the per-
iphery (Phase I: syncytial blastoderm). During cellulari-
zation (Phase II), lipid droplets move inwards, deplete
from peripheral regions, and accumulate around the
central yolk. This accumulation reverses during gastrula-
tion (Phase III): the droplet population shifts outward
and disperses throughout the embryo periphery. These
shifts can be revealed by staining fixed embryos with the
lipid-droplet specific dye Nile Red (Figure 3A) or by
observing living embryos under transmitted light (Figure
3B): Since lipid droplets scatter light, cytoplasm full of
droplets is opaque, while cytoplasm depleted of droplets
is transparent [19]. As a result, wild-type embryos have
a clear periphery in Phase II (not shown) and a cloudy
periphery in Phase III (Figure 3B).
Klar b is important for the correct balance between
plus- and minus-end motion. In the absence of Klar b,
the global droplet distribution in Phases I and II is
Klar ` 250 kDa
A
B
k
l
a
r
Y
G
3
k
l
a
r
Z
k
l
a
r
M
W
k
l
a
r
1
w
i
l
d
 
t
y
p
e
klarMW  klarZ  klarYG3 
Figure 2 Klar
MW is expressed in embryos, but not localized to
lipid droplets. (A) Klar Western of embryos (cycle 14/Phase II) of
various genotypes. Since klar
MW and klar
Z are present on TM6B
balancer chromosomes, these alleles were analyzed in combination
with Df(3L)emc
E12, a deletion that encompasses the entire klar locus.
The Klar
MW protein is expressed and stable, as it accumulates to
similar levels as the wild-type protein Klar
Z. (B) Embryos were
centrifuged to separate organelles by density, fixed and stained for
Klar. The lipid-droplet layer was recognized by its distinctive
appearance by bright-field microscopy. In this image, embryos are
arranged with the lipid-droplet layer pointing up. Klar signal is
enriched on the droplet layer in klar
Z embryos, but not detectable
on the droplet layer when the LD domain is truncated (klar
MW)o r
Klar b is not expressed (klar
YG3).
Wild Type klarYG3
klarMW klarZ
GFP-LD klarYG3
Z3-1711 Tai255.1
GFP-LD
Wild Type klarYG3 klarMW
Phase I
Phase III
Phase II
B
A
Figure 3 The klar
MW allele does not support normal lipid-
droplet transport in embryos. (A) Embryos were fixed and stained
with Nile Red to reveal lipid droplets. In all genotypes shown, lipid
droplets are spread throughout the periphery in Phase I and move
inward in Phase II. In the wild type, lipid droplets shift back into the
periphery in Phase III. In klar
YG3 and klar
MW, the bulk of lipid droplets
remains in the central yolk in Phase III. (B) Living embryos were
placed in halocarbon oil and imaged by bright-field microscopy
after Phase III, as described [19,22]. Embryo transparency reveals
global lipid-droplet distribution [19]. Klar
YG3, klar
MW, and GFP-LD
klar
YG3 embryos display a transparent periphery, indicating that lipid
droplets failed to spread out from their inward accumulation in
Phase II. For all other genotypes shown, embryos are opaque,
characteristic of normal outward droplet transport. Normal transport
in the wild-type strain Tai255.1 has been observed previously [58].
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Page 5 of 15similar to the wild type, but becomes dramatically differ-
ent in Phase III: lipid droplets remain around the center,
instead of shifting back to the periphery. To assess if the
LD domain contributes to Klar’sf u n c t i o ni nt h i st r a n s -
port process, we compared klar
MW and klar
Z embryos.
In both genotypes, the periphery turned clear in Phase
II (not shown), just like for all other klar alleles pre-
viously characterized. In Phase III, klar
Z embryos were
opaque, like the wild type; a single copy of klar is indeed
sufficient to support normal net droplet transport in
Phase III [19]. In contrast, klar
MW embryos were clear,
very similar to embryos lacking Klar b altogether (Figure
3B). This droplet mislocalization was confirmed by Nile
Red staining (Figure 3A): In klar
MW embryos, droplets
accumulate around the central yolk in Phase II, and stay
centrally in Phase III. Thus, klar
MW behaves like a Klar
b loss-of-function allele. We conclude that the LD
domain is essential for Klar b function. Since it also dis-
rupts the localization of Klar b to droplets, we conclude
that proper targeting to droplets is necessary for Klar b
to control droplet motion. Presumably, Klar b has to be
in close proximity to the motors it regulates.
Sequence variation in the LD domain
The TILLING approach had uncovered a second strain
(Z3-1770) with mutations in exon 15ext. We verified
those changes by genomic sequencing; they are pre-
dicted to result in amino-acid changes at five positions
(Figure 1A). In addition, in a survey of various labora-
tory strains, we found three amino-acid changes in
Tai255.1, a stock collected from the wild in 1983. None
of these changes apparently compromise Klar’s function:
In both strains, Klar localized to lipid droplets (data not
shown), and lipid droplets displayed normal outward
transport in Phase III (Figure 3B).
To identify other positions in the LD domain at which
variation can be tolerated, we compared the sequence of
this domain across seventeen fly species (Figure 1B).
More than half of the LD domain displays dramatic
sequence variation over this evolutionary time span
(~250 Mya). But a 46 amino-acid stretch is highly con-
served: 31 positions were either identical or similar
among these species. This conservation suggests that
this region is functionally important, likely for droplet
targeting. This region is deleted in the non-targeting
klar
MW allele (arrow in Figure 1B).
The LD domain truncation supports nuclear migration in
photoreceptors
Besides droplet transport, the best-characterized role of
Klar is in the migration of nuclei in developing photore-
ceptors [19,24]. Here, Klar localizes to the nuclear envel-
ope [24], and has been proposed to act as an anchor for
cytoplasmic dynein [36]. Numerous lines of evidence
suggest that this transport process requires the Klar a
isoform [22,24], but the available data do not clearly
address if - in addition to Klar a -K l a rb is also
required to support nuclear migration. This uncertainty
is in large part due to the fact that previously it was not
possible to selectively abolish just Klar b function with-
out also affecting Klar a [22,27]. Klar
MW now provides
a unique opportunity to address if Klar b is required for
proper positioning of photoreceptor nuclei.
To reveal the position of photoreceptor nuclei in
third-instar eye discs, we employed the marker Elav
(Figure 4). We then examined apical and basal focal
planes of these discs for the presence of Elav-positive
nuclei. In the wild type (not shown) and in klar
Z,o n l y
the apical sections had nuclei, indicating successful
migration of nuclei. In klar
YG3 (both Klar a and Klar b
disrupted), nuclei were present in both apical and basal
sections, indicating disrupted nuclear migration; nuclei
were also found in the optical nerve. In klar
MW eye
discs, nuclei were apical and not present basally nor in
the optical nerve. Thus, Klar b is not essential for apical
positioning of photoreceptor nuclei.
A GFP-tagged LD domain localizes to embryonic lipid
droplets
The previous analysis established that the LD domain is
necessary in vivo for the droplet localization of Klar as
well as for Klar’s role in regulating droplet transport. To
address whether the LD domain is sufficient for these
functions, we generated transgenes to allow Gal4-
mediated expression of a GFP-LD fusion protein. Since
the lipid droplets of the early embryo originate during
oogenesis, we combined these transgenes with Gal4 dri-
vers specifically expressed in the female germ line
klarYG3 klarMW klarZ
apical
basal
ON ON
ON
Figure 4 The klar
MW allele supports nuclear migration in
photoreceptors. Eye discs from third-instar larvae were fixed,
stained with anti-Elav to reveal photoreceptor nuclei and examined
by confocal microscopy. In klar
Z discs, the photoreceptor nuclei are
present in apical positions; a few nuclei are visible in the basal
section because the disc curves at the edges. Nuclei are absent
from the optical nerve (ON). This is the pattern observed in wild-
type discs [22,24]. In klar
YG3 discs, many nuclei are found basally and
in the optical nerve because apical migration of nuclei has failed.
Klar
MW discs display the wild-type pattern.
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produced when those lipid droplets are first generated.
Western analysis confirmed that GFP-LD was expressed
in ovaries and embryos (Figure 5A, B). Molecular weight
standards indicate that its apparent molecular weight is
in good agreement with the predicted molecular weight
of 41.4 kDa (data not shown).
To determine the intracellular distribution of GFP-LD,
we detected GFP fluorescence in living and in fixed
embryos or stained fixed embryos with anti-GFP antibo-
dies. All three methods revealed that the fusion protein
was present in discrete puncta (Figure 5C, and data not
shown), reminiscent of lipid droplets in size and abun-
dance. These GFP-LD puncta moved actively, in a back-
and forth manner (see the movies provided as Additional
Files 1 and 2), similar to the bidirectional movement of
lipid droplets [19]. In addition, the global distribution of
GFP signal also mimicked that of lipid droplets (Figure
5E). The generally peripheral distribution in Phase I was
followed by accumulation around the central yolk in
Phase II. In Phase III, GFP-LD was again broadly
peripheral.
If GFP-LD indeed marks lipid droplets, its distribution
should change predictably if lipid-droplet transport is
altered. Inward transport of lipid droplets in Phase II
requires the transport regulator Halo; in its absence,
lipid droplets accumulate close to the plasma mem-
brane, under the nuclei, rather than around the yolk in
the center [18]. Halo has no known role in the transport
of any cargo beyond lipid droplets. In embryos lacking
Halo, GFP-LD puncta also accumulate under the nuclei
(Figure 5D), instead of around the yolk (Figure 5C).
Furthermore, outward transport of lipid droplets in
Phase III requires Klar b (Figure 3A). In the absence of
endogenous Klar b,G F P - L Dr e m a i n e dh i g h l ye n r i c h e d
in the yolk sack in Phase III (Figure 5E), just like lipid
droplets [19,22]. Thus, in these genotypes, GFP-LD dis-
tribution reflects the distribution of lipid droplets.
Finally, at higher magnification, the GFP-LD struc-
tures appeared as rings (Figure 6C, D), in the known
size-range of embryonic lipid droplets (~500 nm in dia-
meter). Such ring structures are very characteristic for
lipid droplets, as droplet proteins accumulate at the dro-
plet surface and are excluded from the hydrophobic core
full of neutral lipids [37]. Rings of GFP-LD were appar-
ent in both fixed and living embryos. Co-staining of
fixed embryos with the droplet-specific dye Nile Red
revealed that GFP-LD signal was present around Nile-
Red positive structures (Figure 6C, D). We conclude
that the GFP-LD puncta are lipid droplets.
There are two unexpected patterns of the GFP-LD
signal. First, it is present in fairly uniform rings, rather
than the discrete spots observed for endogenous Klar b
[22]. Full-length Klar b might be restricted to certain
Figure 5 GFP-LD distribution in early embryos.( A ,B )W e s t e r n
analysis of wild-type (WT) and GFP-LD expressing (GL) animals. GL
samples are from females carrying both a GFP-LD transgene and
the mata4-Gal4-VP16 driver or from embryos laid by these females.
GFP-LD was detected with anti-GFP antibodies; corresponding WT
samples demonstrate specificity of detection. (A) GFP-LD is present
in both ovaries and embryos. (B) GFP-LD is expressed at similar
levels in Phase I, II, and III embryos. Tubulin serves as loading
control. (C, D) GFP-LD expressing embryos examined live by
confocal microscopy. In otherwise wild-type embryos, GFP-LD is
present in distinct puncta that accumulate around the central yolk
(C). In embryos mutant for Halo, GFP-LD puncta accumulate just
under the nuclei (D); these puncta are shifted outwards relative to
the embryos in C. Top: whole-embryo view. Bottom: detail of the
embryonic periphery. The embryos in C and D are age-matched
(top: early Phase II; bottom: mid Phase II). Scale bars in D represent
60 μm (top) and 10 μm (bottom), respectively. (E) GFP-LD
expressing embryos imaged live by epifluorescence microscopy.
Comparison to a wild-type embryo demonstrates that most of the
signal is due to GFP-LD. Global distribution of GFP-LD in Phases I, II,
and III mimics the distribution of lipid droplets at these embryonic
stages (Fig. 3A); in particular, GFP-LD is spread throughout the
periphery in Phase III if endogenous Klar b is present, but not if it is
absent. (F) Even when expressed in the absence of endogenous Klar
b, GFP-LD is present in discrete puncta (scale bar = 6 μm). (G)
Triglyceride levels in wild-type and GFP-LD expressing embryos
(0-1.5 hrs old) are very similar. Error bars represent the standard
deviation from two different experiments.
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N-terminal region with other proteins. Alternatively, the
binding partners that keep Klar b locally restricted may
be limiting, present in lower amounts than the well
expressed GFP-LD. Second, only some of the Nile-Red
positive structures display strong GFP-LD signal (Figure
6C, D), while on others GFP levels were much weaker
or barely detectable. It is striking that drastic intensity
variations can be observed between neighboring lipid
droplets in the same cell. This observation suggests that
GFP-LD displays differential affinity to different droplets
or that, once droplets are generated with distinct GFP-
LD levels, GFP-LD does not readily exchange between
droplets.
GFP-LD localizes to droplets in the absence of
endogenous Klar b
The above analysis suggests that the LD domain is suffi-
cient to target an unrelated protein to lipid droplets. This
conclusion, however, might be misleading if the LD
domain were a dimerization motif. In that case, GFP-LD
could physically interact with full-length Klar b and would
be targeted to lipid droplets secondarily, even if full length
Klar were to bind to the droplets via other domains.
Although the analysis of klar
MW makes this possibility
unlikely, we performed a rigorous test of this idea by
examining GFP-LD in a Klar b null background. GFP-LD
was still present in distinct cytoplasmic rings the size of
lipid droplets (Figure 5F) that moved bidirectionally (not
shown). In addition, global GFP-LD distribution followed
that of lipid droplets: throughout the periphery in Phase I,
and accumulated in or around the central yolk in Phases II
and III (Figure 5E). Thus, GFP-LD localization to lipid
droplets does not require endogenous Klar b.
The GFP-LD fusion co-purifies with lipid droplets
Lipid droplets are rich in neutral lipids and have a low
buoyant density. This property makes it possible to bio-
chemically separate droplets from other cellular struc-
tures. We therefore asked if GFP-LD copurifies with
lipid droplets. In a first test, we employed in-vivo centri-
fugation of intact embryos [35]. In such centrifuged
embryos, GFP-LD signal was highly enriched in the
lipid-droplet layer (Figure 6A), just like endogenous Klar
(Figure 2B). This enrichment is not due to the GFP por-
tion as many other GFP fusion proteins are excluded
from the droplet layer in this assay [11]. It also does not
depend on endogenous Klar b since GFP-LD was
enriched in the droplet layer in the Klar b null back-
ground (Figure 6A). Second, we lysed embryos and
enriched for droplets using a sucrose step-gradient
(Figure 6B). The top, lipid-droplet fraction was highly
depleted for the cytoplasmic protein tubulin and greatly
enriched for the bona-fide lipid-droplet protein LSD-2.
GFP-LD was similarly enriched in this fraction. Taken
together, these two approaches demonstrate that GFP-
LD co-purifies with lipid droplets and provide indepen-
dent evidence that the LD domain is sufficient to target
an unrelated protein to lipid droplets.
The LD domain mediates droplet localization in
many cell types
How proteins are targeted to lipid droplets is not well
understood [1]. Droplet-localized proteins fall into two
Figure 6 GFP-LD puncta are lipid droplets. (A, B) GFP-LD
co-purifies with lipid droplets. (A) Pre-cellularization embryos were
embedded in agar and centrifuged. In the image, the embryos are
arranged such that the lipid-droplet layer points up. GFP-LD is highly
enriched in the droplet layer, whether or not the embryos express
endogenous Klar b. Under the same imaging conditions,
autofluorescence in wild-type embryos is negligible. (B) Lipid droplets
were isolated from wild-type (WT) and GFP-LD expressing (GL)
embryos by floatation. Equal amounts of protein from embryo lysates
(Lys) and from the droplet fraction (DF) were compared by Western
analysis. The cytoplasmic protein tubulin is absent from the droplet
fraction. Both the lipid-droplet protein LSD-2 and GFP-LD are highly
enriched in the droplet fraction. GFP-LD was detected as in Fig. 5.
(C, D) GFP-LD expressing embryos were fixed and stained with Nile
Red to reveal lipid droplets. GFP-LD is present in rings around lipid
droplets; intensity of GFP-LD signal varies between droplets (scale bar
=5μm). Panel D shows a magnified view of parts of panel C.
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in essentially all cells they are expressed in, such as the
Perilipin family members PLIN1and PLIN2 (formerly
called Perilipin and ADRP, respectively) [21,38]. This
constitutive localization is in contrast to the condi-
tional recruitment of, e.g., hormone-sensitive lipase;
this enzyme moves from a general cytoplasmic distri-
bution to the surface of lipid droplets in response to
hormonal signaling [39]. In addition, specific proteins
from other cellular compartments localize to lipid dro-
plets only in certain developmental stages or under
specific environmental conditions [40]. For early
embyronic droplets in Drosophila, certain histones are
such conditional lipid-droplet proteins [11]; many
more proteins potentially behave similarly as the pro-
teomes of embryonic and of fat-body droplets show
considerable differences [11,41]. We therefore asked
whether localization of GFP-LD occurs only in early
embryos or is a general phenomenon.
W ef i r s te x a m i n e do v a r i e ss i n c el i p i dd r o p l e t sa r e
abundant in nurse cells and in oocytes from mid-oogen-
esis onwards. GFP-LD expressed with a Gal4 driver spe-
cific for the female germ-line (mata4-Gal4-VP16)
accumulates during oogenesis (Figure 5A), and is pre-
sent in ring structures in both oocytes and nurse cells
(Figure 7A, B). These rings co-stained with Nile Red
and are apparently of low buoyant density: In centri-
fuged ovaries, where the major constituents of nurse
cells and oocytes sort out by density [11], GFP-LD was
highly enriched in the lipid-droplet layer (Figure 7C).
We conclude that GFP-LD is present on lipid droplets
in oocytes and nurse cells.
Using the ubiquitously active Act5C-Gal4 driver, we
also expressed GFP-LD in somatic cells. In a number of
adult and larval tissues, we found discrete GFP puncta,
including in follicle cells in the adult ovary, larval sali-
vary glands, and imaginal discs. These structures are
lipid droplets, as they appear as rings at higher magnifi-
cation and co-label with Nile Red (Figure 7D, E, F).
Since in the wild type lipid droplets are abundant in cer-
tain imaginal discs [42], in follicle cells (MAW, unpub-
lished observations), as well as in nurse cells and
oocytes [43], GFP-LD likely does not induce lipid
storage de-novo in these tissues, but localizes to pre-
existing droplets.
In summary, targeting of the LD domain to lipid dro-
plets is not an embryo-specific phenomenon. GFP-LD
also localizes to lipid droplets in the female germ line
and in a number of somatic tissues. In addition, an ana-
logous RFP-LD fusion protein localizes to lipid droplets
in cultured Drosophila cells [22]. Thus, GFP-LD is not a
conditional droplet protein, and the mechanism target-
ing the LD domain to lipid droplets is quite general.
Discussion
A klar allele specific for the Klar b isoform
Because the klar locus encodes at least three proteins
with different exon content, different lesions in klar
have distinct effects on the isoforms and thus on dis-
tinct biological processes [22]. Lesions in exons 0
t h r o u g h1 5d i s r u p tb o t hK l a ra and Klar b; these so-
called class I alleles impair both nuclear migration in
photoreceptors and motion of embryonic lipid droplets.
Lesions in exons 16 through 18 disrupt Klar a and Klar
g; such class II alleles impair nuclear migration, but not
droplet motion. The new allele klar
MW disrupts Klar b
but not Klar a; it alters droplet motion but not nuclear
migration. It constitutes a new type of allele (class III)
that selectively impairs the b isoform.
Klar
MW provides a unique tool to separately examine
the functions of Klar a and Klar b.K l a ri sw i d e l y
expressed [22] and has been implicated in a number of
biological processes beyond droplet motion and nuclear
migration [23,44-48]. In most cases, it is unknown
which Klar isoform is involved. The combination of
class I, II and III alleles should make it possible to dis-
entangle this functional complexity.
Droplet targeting by the LD domain
Our analysis of GFP-LD fusions suggests that targeting
of Klar b to lipid droplets is a multi-step process. In
many cells, GFP-LD strongly accumulates on lipid dro-
plets (Figure 6, 7). In mid-stage oocytes, in follicle cells,
and in the salivary gland, GFP fluorescence is also
detected diffusely and in membranous structures and
tubules reminiscent of the nuclear envelope or the ER
(not shown). Under sensitive imaging conditions, similar
additional GFP-LD distribution becomes apparent also
in early embryos. These observations suggest that - in
addition to strong affinity to lipid droplets - GFP-LD
has a weak affinity to certain membranous compart-
ments. We do not know yet whether this additional
localization represents nascent GFP-LD in transition to
lipid droplets, ectopic localization due to high levels of
expression, or genuine multiple targeting. Dual localiza-
tion of proteins to both the ER and lipid droplets is
common, presumably because lipid droplets originate
from the ER [1].
Nevertheless, GFP-LD clearly accumulates strongly on
lipid droplets in many tissues, forming characteristic
ring structures. Intriguingly, this distribution is distinct
from the distribution of full-length Klar b, which is pre-
sent in discrete dots on embryonic droplets [22], a dis-
tribution similar to that of the motor dynein [14]; thus,
full-length Klar may be recruited to distinct spots by
physical interactions with microtubule motors. GFP-LD
may not be restricted to such dots because interactions
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Page 9 of 15Figure 7 GFP-LD fusion protein localizes to lipid droplets in many types of cells. The intracellular distribution of GFP-LD was examined in
animals expressing GFP-LD in the female germ line (A, B, C: mata4-Gal4-VP16 driver) or in somatic cells (D, E, F: Act5C-Gal4 driver).
Colocalization with Nile Red signal (A, B, D, E, F) or enrichment in the lipid-droplet layer after centrifugation (C) indicates that GFP-LD is
associated with lipid droplets. (A) Stage 13 oocyte. (B) Stage 10 nurse cells. (C) Egg chamber after centrifugation. Bright-field microscopy (BF)
reveals distinct layering. Prominent brown lipid-droplet layers are evident in the nurse cells (left) and the oocyte (right); the oocyte also shows a
gray yolk layer. GFP-LD is enriched in the droplet layers of both nurse cells and oocyte. The merged image also shows yolk autofluoresence in
blue. (D) Follicle cells. (E) Larval salivary gland. (F) Wing imaginal disc. In all cases, the intensity of GFP-LD signal varies dramatically between lipid
droplets. GFP-LD signal was also present, at lower levels, elsewhere in the cell (e.g., E). Scale bars = 5 μm.
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inal region of Klar b or because GFP-LD is overex-
pressed relative to its interaction partners. We favor the
former explanation since even those lipid droplets with
comparatively low GFP-LD signal show a ring-like dis-
tribution of GFP-LD (Figure 6C, D). In the future, these
hypotheses can be distinguished by comparing the dis-
tribution of GFP-LD and GFP-Klar b expressed at simi-
lar levels.
What is the molecular mechanism by which the LD
domain, a region just 114 amino acids in length, is
recruited to lipid droplets? Evolutionary conservation
and mutational analysis point to a 46 amino acid region
as critical for targeting (Figure 1B). Many proteins loca-
lize to droplets via hydrophobic targeting motifs thought
to insert into the phospholipid monolayer surrounding
droplets and to make contacts with the hydrophobic
core. Examples include the proline knot motif of plant
oleosins [49], hydrophobic patches in caveolin [50] or
amphipathic helices in various Perilipin family members
[21]. Consistent with this possibility, the 46 aa con-
served region of the LD domain is fairly hydrophobic
(light blue residues in Figure 1B) and the regular inter-
spersion of charged residues is compatible with this
region forming an amphipathic helix (Figure 1C). Alter-
natively, this motif may allow the LD domain to physi-
cally interact with resident droplet proteins, e.g.j u s tl i k e
hormone-sensitive lipase is recruited to droplets by
binding to PLIN1 [39]. If so, the binding partners of the
LD domain cannot be exclusive to embyronic droplets
since droplet targeting occurs in many types of cells
(Figure 7). As a first step towards uncovering the target-
ing mechanism, a structure-function analysis of this
region should reveal which features of the sequence
(e.g., general hydrophobicity versus specific residues) are
essential for proper droplet targeting. These studies can
be conducted in the more accessible cultured-cell sys-
tem, since the LD domain shows the same targeting
properties in vivo (Figure 6, 7) as in cultured cells [22].
Since GFP-LD localizes to the droplet surface, it might
potentially interfere with lipid metabolism. For example,
in cultured mammalian cells, overexpression of PLIN2
promotes lipid-droplet accumulation, presumably by
shielding the droplets from access by lipases [51,52]. We
have not noticed dramatic effects on lipid storage upon
GFP-LD overexpression. Total triglyceride levels in
wild-type and GFP-LD expressing embryos are very
similar (Figure 5G), and in a range of cell types, lipid
droplets carrying high levels of GFP-LD are very similar
in size to nearby droplets with low GFP-LD levels
( F i g u r e6a n d7 ) .T h e s ed a t ad on o tr u l eo u tt h a tG F P -
LD causes minor quantitative changes in lipid storage or
only produces effects in specific cell types or under cer-
tain physiological conditions.
Why is GFP-LD distribution not uniform?
It is striking that not all lipid droplets accumulate GFP-
LD to the same level. Lipid droplets in close proximity
in the same cell can have dramatically different GFP-LD
signal (Figures 6, 7). An exciting development in recent
years has been the realization that not all lipid droplets
within a given cell are identical; in particular, they can
carry different proteins [37,38,41,53]. However, the lipid
droplets in early Drosophila embryos appear quite uni-
form, in size distribution and motile behavior [14,18,19];
d r o p l e tp r o t e i n sp r e v i o u s l ye x a m i n e dd i s p l a y e dn o
obvious variation between droplets [11,20]. To our
knowledge, the uneven distribution of GFP-LD is the
f i r s th i n tt h a td i f f e r e n te m b y r o n i cd r o p l e t sm i g h th a v e
distinct properties.
Currently, we cannot distinguish whether GFP-LD is
preferentially recruited to certain types of droplets exist-
ing naturally or whether GFP-LD expression causes dif-
ferences between droplets. For example, Gal4 drivers
often show mosaic expression in nurse cells [54]; and
we sometimes observed, in the same egg chamber, nurse
cells with variable GFP-LD expression (data not shown).
Droplets that originated in different nurse cells may
therefore carry distinct levels of GFP-LD once they
reach the oocyte. We suspect that such mosaic expres-
sion does not fully account for the differential labeling
because we observe drastic variation in GFP-LD levels
also between droplets in single nurse cells as well as in
other cells (Figure 7).
The role of the LD domain for droplet transport
The LD domain is necessary not only for droplet locali-
zation of Klar b,b u ta l s of o rK l a rb’sf u n c t i o ni nr e g u -
lating droplet transport. Our results indicate that
although the LD domain is sufficient for droplet locali-
zation, by itself it does not mediate Klar’s transport
functions. When expressed in the Klar b null back-
ground, most GFP-LD signal remains in the yolk sack in
Phase III (Figure 5E). In addition, Klar b null embryos
remain clear in Phase III, whether or not they express
GFP-LD (Figure 3B). Simply targeting GFP-LD to lipid
droplets is apparently not sufficient to restore Klar b’s
function.
Although it is conceivable that GFP-LD expression
levels were simply not high enough for rescue of the
transport defects, we disfavor this explanation since a
full-length, GFP-tagged Klar b construct expressed at
much lower levels is sufficient to profoundly alter dro-
plet motion (YVY and MAW, unpublished observa-
tions). We therefore conclude that proper regulation of
droplet motors requires the N-terminal region of Klar b
and not just the LD domain. This model is further sup-
ported by the fact that Klar a shares those N-terminal
regions and is also involved in motor regulation.
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droplets or has additional functions is not yet clear. For
example, because in yeast the LD domain can interact
with the droplet protein LSD-2, it has been suggested
that it participates in transmitting developmental signals
from LSD-2 via Klar to motors [20]. In the future, it will
be interesting to investigate whether expression of GFP-
LD alters subtle aspects of droplet motion, e.g., the
exact distances traveled in a single run or the frequency
of pausing [14].
However, our data suggest that such effects, if they
exist at all, do not alter the net outcome of transport.
GFP-LD expressing embryos displayed the same trans-
parency changes as the wild type: the embryo periphery
became transparent in Phase II and cloudy in Phase III
(Figure 3B, and data not shown). Also, in the presence
of GFP-LD, inward droplet transport in Phase II still
depends on Halo (Figure 5D) and outward droplet
transport in Phase III depends on endogenous Klar b
(Figure 5E), just as for embryos not expressing the
fusion protein [18]. These conclusions hold true
whether we examine transparency changes in the
embryos (to reveal the behavior of the entire droplet
population) or GFP fluorescence directly (Figure 3B;
Figure 5D, E).
Since LD has the ability to bind to lipid droplets in a
wide range of cells, Klar b may control droplet motility
in many tissues. In Drosophila, droplet motion has so
far been described only in early embryos [19] and in
oocytes [55], but no systematic analysis has been con-
ducted. New GFP fusions to mark lipid droplets in vivo
[37,56], including the GFP-LD constructs described
here, will make it possible to address to what extent
droplets move in other tissues and whether disruption
of Klar b alters that movement.
Conclusions
To test the function of the LD domain of Klar b,w e
generated inducible GFP-LD fusion constructs and iden-
tified a klar allele that specifically disrupts the LD
domain. Using these tools, we demonstrate that the LD
domain is both necessary and sufficient for droplet tar-
geting in vivo.W ec o n c l u d et h a tK l a rb is targeted to
lipid droplets via an isoform-specific protein motif, just
like Klar a is targeted to the nuclear envelope via the
KASH domain. Thus, it is controlled inclusion of cis-
acting targeting sequences that mediates the differential
intracellular localization of Klar in distinct tissues.
Although Klar’s LD domain is necessary for Klar b to
act in the regulation of lipid-droplet transport, by itself
it does not mediate Klar’s transport functions. Likely it
is the N-terminal regions shared between Klar a and
Klar b that mediate motor regulation. In this model,
variable C-terminal targeting sequences control Klar’s
intracellular distribution and thus dictate which subset
of intracellular motors is controlled by Klar.
Methods
Fly stocks
Oregon R was used as the wild-type stock. The stocks
carrying klar alleles klar
YG3 and klar
1 and the deficiency
Df(3L)emc
E12 were described previously [19,22]. The col-
lection of mutagenized third chromosomes was gener-
ated by the Zuker laboratory [31]. Line Z3-1711 might
represent a different chromosome than the others from
the collection: it did not display the recessive eye color
markers characteristic for these stocks [31], and it had
five simultaneous amino-acid changes in the LD domain
(Figure 1A). However, for the purposes of the analysis
described here, the exact origin of this chromosome is
not important. The critical information is the presence
of these mutations in the LD domain and the wild-type
phenotype for droplet transport and Klar localization.
Tai255.1 is a wild-type D. melanogaster strain isolated
in 1983 at Ivory Coast [57]; it displays normal net dro-
plet transport [58].
To generate the GFP-LD expressing flies, GFP was
amplified from pEGP-C1 (Clontech) and cloned into the
KpnIa n dNotI sites of pUASp [54]. A tobacco etch
virus (TEV) protease site (GAGAATTTGTATTTT-
CAGGGT) was generated by oligo nucleotide synthesis
and cloned 3’ to the GFP gene. The LD domain was
amplified from cDNA clone LD08331 [22] and cloned
in frame 3’ to the TEV site. The resulting plasmid was
injected into Drosophila embryos by Genetic Services,
Inc. (Cambridge, MA). Transgenic flies were selected by
eye color. In total, twenty lines mapping to the X, sec-
ond or third chromosome were established. To express
the fusion proteins, transgenic animals were crossed
with lines carrying matb4-Gal4-VP16 or Act5C-Gal4
drivers.
TILLING, genomic sequencing, and sequence analysis
TILLING analysis was performed by the Fly-TILL ser-
vice as described [32]. In ~6000 strains from the Zuker
collection [31], we screened a 1519 bp genomic region
from the end of exon 12 through the coding region of
exon 15ext. Nucleotide changes were uncovered in 23
lines; in two cases (Z3-1711 and Z3-3772), these
changes mapped to exon 15ext. For these two strains,
we sequenced PCR products encompassing exon 15ext
as described below. The nucleotide changes observed in
line Z3-3772 were due to changes on the balancer chro-
mosome (see main text for details).
DNA primers were created to bookend individual
exons of klar piecemeal using annealing temperatures
and GC content to determine the most effective oligo
sequences (primer sequences available upon request).
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PCR amplify these genomic fragments. PCR products
were depleted of free nucleotides with ExoSAP-IT and
sequenced at the Life Sciences Core Laboratories Center
at Cornell University. Sequencing results were compared
to the canonical sequences available on FlyBase.
To determine the pattern of evolutionary conservation
in the LD domain, we first identified the likely klar exon
1 5i nt h ea v a i l a b l eg e n o m ea n n o t a t i o n sf o rt h eDroso-
phila and mosquito species accessible via the FlyBase
BLAST server. We also identified related sequences
from the G. morsitans genome project (Sanger Institute)
as well as in a cDNA from the medfly C. capitata
(GenBank # FG077614.1). In Drosophila melanogaster,
exon 15ext follows immediately downstream of exon 15.
In all 16 additional fly species examined, the corre-
sponding DNA sequences downstream of exon 15 have
the potential to encode proteins with significant similar-
ity to the D. melanogaster LD domain (Figure 1B).
These protein sequences were aligned with Clustal2.
The helical wheel in Figure 1C was drawn using the
helical wheel plotting script from the Zidovetzki labora-
tory, UC Riverside http://rzlab.ucr.edu/scripts/wheel/
wheel.cgi.
In-vivo centrifugation, fixation, immunostaining, and
imaging
Living embryos were centrifuged to separate lipid dro-
plets from other cellular components, as described [35].
Embryos were either embedded in agar to keep them in
a fixed orientation during centrifugation, or they were
centrifuged in random orientations in microcentrifuge
tubes filled with buffer, and the lipid-droplet layer was
identified by its characteristic appearance by bright-field
microscopy. To separate organelles by density in oocytes
and nurse cells, females were centrifuged in buffer-filled
microfuge tubes as described [11].
To stain lipid droplets, dechorionated embryos or dis-
sected fly tissues were fixed in 4% formaldehyde in PBS
for 10-15 min using standard procedures [59,60]. For
embryos, this treatment is sufficient to make the vitel-
line membrane permeable to Nile Red. After washing,
these samples were suspended with 1% BSA in PBS and
stained with Nile Red at 20 μg/ml. In some cases (Figure
7D, E, F), unfixed tissues were directly stained with Nile
Red. For immunodetection of GFP or Klar, dechorio-
nated embryos were heat fixed and devitellinized using
standard heptane-methanol procedures [59,60]. They
were stained either with mouse monoclonal Klar-M as
described [22] or with rabbit anti-GFP (Torrey Pines
Biolabs) at 1:10,000. Before use, the anti-GFP antibody
was exposed to heat-fixed wild-type embryos to remove
cross-reacting antibodies.
Two approaches were employed to examine GFP-LD
fluorescence in living embryos. For confocal microscopy,
embryos were hand-dechorionated, placed in halocarbon
oil on a glass slide, and covered with a cover glass that
was supported by spacers. For epifluorescence micro-
scopy, embryos were placed into halocarbon oil on a
glass slide. The halocarbon oil turns the chorion trans-
parent (see Figure 3B).
Micrographs were acquired on a Leica SP5 confocal
microscope or a Nikon Eclipse E600 fluorescence micro-
scope with a 4MP Spot Insight camera. Images were
processed in Adobe Photoshop and assembled with
Adobe Illustrator.
Western analysis
For Western analysis, proteins were typically separated
on a 10% SDS PAGE gel and transferred to PVDF mem-
branes using standard Towbin or CAPS transfer. Mouse
anti- alpha tubulin (Sigma-Aldrich) was used at
1:10,000, and mouse anti-GFP (Roche) at 1:1000. LSD-2
was detected with a rabbit polyclonal anti-serum [20] at
1:20,000. To consistently detect Klar b, this general pro-
cedure was optimized: Proteins were separated on 6%
gels, and transferred in 25 mM Tris, 192 mM glycine,
10% methanol, 0.01% SDS to PVDF membranes (2 hrs
at 100 V). Membranes were sequentially exposed to
Klar-M (1:50, overnight at 4°C), rat anti-mouse IgG
(1:1000; 1 hr at room temperature) and HRP-conjugated
goat anti-rabbit IgG (1:1000; 1 hr at room temperature).
Droplet purification
To generate samples enriched in lipid droplets, we adapted
the protocol described previously [11]. For each genotype,
150 μl of embryos (0-3 hrs old) were dechorionated, resus-
pended in 300 μl TKM (50 mM Tris, pH 7.4, 25 mM KCl,
5 mM MgCl2) containing 1 M sucrose plus protease inhi-
bitor cocktail (Sigma-Aldrich), and then mechanically dis-
rupted on ice. The lysate was transferred to a fresh 1.5 ml
tube and overlaid sequentially with 200 μl TKM contain-
ing 0.5 M sucrose, 200 μl TKM containing 0.25 M sucrose,
and 400 μl TKM. After centrifugation at 1000 g for 5 min,
5000 g for 5 min and 13400 g for 10 min, the buoyant
lipid droplets were collected from the top of the gradient.
The amount of protein in the isolated lipid droplets was
measured by Bradford protein assay (Quick Start, Bio-Rad)
before solubilizing the lipid droplets in SDS-containing
buffer for subsequent SDS-PAGE analysis. Fractions such
prepared are similar to those described by Cermelli et al.
[11]: the overall pattern of major Coomassie-stainable pro-
teins is similar; the droplet protein LSD-2 and several his-
tones are consistently enriched, and the cytoplasmic
protein tubulin is absent (Figure 6B; Li and Welte, unpub-
lished observations).
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Embryos were collected for 1.5 hr, dechorionated with
50% bleach, and resuspended in triton salt solution
[59,60]. 200 embryos before cellularization stages were
handselected, resuspended in 200 μl homogenizing buf-
fer (0.01 M KH2PO4, 1 mM EDTA, pH 7.4), and
mechanically disrupted. 40 μl of this lysate were mixed
with 1 ml activated Triglyceride Reagent (Liquicolor Tri-
glycerides, Stanbio), and triglyceride levels were deter-
mined according to the manufacturer’s instructions. For
each experiment, three independent samples were ana-
lyzed per genotype, and the data shown in Figure 5G
are based on two independent experiments.
Additional material
Additional file 1: Motion of GFP-LD puncta in living embryos.
Images were acquired by confocal microscopy at 2.5 images per second.
Playback at 12 frames per second. Scale bar = 7.5 μm.
Additional file 2: Motion of GFP-LD puncta in living embryos.
Images were acquired by confocal microscopy at 1.35 images per
second. Playback at 6 frames per second. Scale bar = 7.5 μm.
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